Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Yi-Long Wu
CONTACT
Qing Zhou
CONTACT
Lead
Guangdong Association of Clinical Trials
This trial has been set up with two arms. Screened patients would be included into one of the arms based on tumor PD-L1 expression. The purpose of this study is to compare the efficacy of the approved checkpoint inhibitor pembrolizumab and home-made drug Sintilimab in patients with advanced NSCLC whose tumor have high PD-L1 expression and low or negative expression.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
